| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |